Serzone Lawsuits
By Aaron Larson
March, 2005
Contents
What is Serzone
Serzone (Nefazodone), developed by Bristol-Myers Squibb, is an antidepressant medication which has been available in the United States since 1994. Serzone was often prescribed for patients experiencing depression combined with anxiety.
Factual Background
Following reports of liver failure in Serzone users, the FDA required Bristol-Myers to place a "black box" warning on the Serzone packet insert. In January, 2003 Serzone was withdrawn from the market in Europe. In November, 2003, Serzone was withdrawn from the market in Canada. In early 2004 Public Citizen, a safety watchdog organization, filed a lawsuit intended to force the FDA to withdraw Serzone from the market. Although it continues to assert that the medication is safe, in May, 2004, citing "business reasons", Bristol-Myers announced that it would stop manufacturing Serzone.
Serzone Litigation
Various law firms are recruiting clients for possible claims or litigation pertaining to Serzone use. Bristol-Myers Squibb asserts that the medication is safe.